StockData
Pfizer Inc logo

Pfizer Inc (PFE) stock

PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Nov 3, 2026Score 9/3048% above fair value
$28.86−0.03 (-0.10%)

Close on Nov 16, 2026Market cap $164.49BP/E 38.0Yield 5.96%

Pfizer pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Pfizer's pe ratio was 38.6× on Nov 10, 2026, against 15.0× a year earlier. Over the last 5 years it ranged from 7.1× to 75.0×, with a median of 15.8×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 10, 202638.6×+24.2
2025Dec 31, 202514.5×−20.9
2024Dec 31, 202435.4×+19.6
2023Dec 29, 202315.7×+5.9
2022Dec 30, 20229.9×−7.5
2021Dec 31, 202117.3×−9.4
2020Dec 31, 202026.7×+13.0
2019Dec 31, 201913.7×+2.7
2018Dec 31, 201811.0×−11.3
2017Dec 29, 201722.4×−9.8
2016Dec 30, 201632.2×+7.9
2015Dec 31, 201524.3×+5.0
2014Dec 31, 201419.2×+10.7
2013Dec 31, 20138.5×−11.0
2012Dec 31, 201219.4×+4.5
2011Dec 30, 201114.9×−7.8
2010Dec 31, 201022.7×+7.7
2009Dec 31, 200915.0×–

More Pfizer figures

See a number that looks wrong?